The Salamol easy-breathe CFC-free inhaler is designed to be a more environmental-friendly option for asthma sufferers, producing as little as 4% of the carbon footprint of alternative inhalers. This is due to the fact the canister is smaller, requiring far less propellant to deliver the same level of active ingredients. But how common are they in the UK right now? We'll address this question by breaking it down into the key components we need to think about.
Why would an asthma sufferer make the switch to a Salamol inhaler?
One of the key reasons the usage of this type of inhaler is becoming increasingly common in the UK is the small environmental impact. Millions of us are becoming increasingly aware of the impact we're having on the environment, as well as what we can do as individual households to play our part in reverse the slide.
One of the primary reasons users cited, when questioned, for making the switch from their previous tried and trusted inhalers was the green credentials of Salamol. This is something other types of inhalers simply cannot compete with because of the inherent nature of their design.
How many people are using Salamol inhalers today?
While exact figures are hard to quantify, many sources cite anywhere from 4-15% of asthma users have either made the switch or are strongly considering it. This is a sizeable increase in the number of people using this type of inhaler when compared to when it was first signed off for use in the UK nearly 20 years ago.
A major part of the usage becoming more and more common is that there's a growing awareness of the medicinal benefits. Salamol is equally as effective as the UK's most commonly prescribed inhaler, meaning that asthma sufferers need not worry about the leave of relief they will get when they unfortunately suffer attacks or general tightness in their lungs. This is a key factor in driving higher and higher adoption rates.
Just how common will Salamol inhalers become in the UK?
This is a hard question to quantify with a degree of certainty, but all the signs are that the trend is set to continue, and potentially gather pace. One factor could well be social awareness where sufferers see friends using a different type of inhaler and ask about why they made the shift.
Ease of availability is another issue that certainly makes a difference to increased adoption rates. You can currently buy them on the High Street via a pharmacist, and also Salamol inhalers are available to purchase at UK Meds. Good news for anyone who wants to be able to access their primary daily medication on a regular basis.
With anywhere from 4-15% of asthma sufferers currently or about to become Salamol users, we could soon see this new type of inhaler occupy at least a quarter of the market. Factor in the increased need to make a difference in the way we all treat the environment and this is a trend which looks set to gather pace by the day.
